{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T08:05:32Z","timestamp":1790841932325,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001411","name":"ICMR","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.dsx.2014.04.035","type":"journal-article","created":{"date-parts":[[2014,7,17]],"date-time":"2014-07-17T21:30:21Z","timestamp":1405632621000},"page":"152-155","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Imbalance between protective (adiponectin) and prothrombotic (Plasminogen Activator Inhibitor-1) adipokines in metabolic syndrome"],"prefix":"10.1016","volume":"8","author":[{"given":"Ashok Kumar","family":"Ahirwar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anju","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binita","family":"Goswami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.K.","family":"Bhatnagar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayashree","family":"Bhatacharjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dsx.2014.04.035_bib0005","series-title":"Harrison's principles of internal medicine","author":"Longo","year":"2012"},{"key":"10.1016\/j.dsx.2014.04.035_bib0010","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0168-8227(03)00085-8","article-title":"Prevalence of diabetes, impaired fasting glucose and insulin resistance syndrome in an urban Indian population","volume":"61","author":"Gupta","year":"2003","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.dsx.2014.04.035_bib0015","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1001\/jama.287.3.356","article-title":"Prevalence of the metabolic syndrome among US adults: findings from the Third National Health and Nutrition Examination Survey","volume":"287","author":"Ford","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.dsx.2014.04.035_bib0020","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/S1262-3636(07)70067-8","article-title":"The incidence and persistence of the NCEP (National Cholesterol Education Program) metabolic syndrome. The French D.E.S.I.R Study","volume":"29","author":"Balkau","year":"2003","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.dsx.2014.04.035_bib0025","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0168-8227(03)00060-3","article-title":"Metabolic syndrome in urban Asian Indian Adults population study using modified ATP III criteria","volume":"60","author":"Ramachandran","year":"2003","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.dsx.2014.04.035_bib0030","first-page":"731","article-title":"Metabolic syndrome and cardiovascular disease in South Asians","volume":"5","author":"Eapen","year":"2009","journal-title":"Vasc Health Risk Manag"},{"issue":"June","key":"10.1016\/j.dsx.2014.04.035_bib0035","first-page":"363","article-title":"The metabolic syndrome and associated risk factors in an urban industrial male population in South India","volume":"58","author":"Kaur","year":"2010","journal-title":"JAPI"},{"issue":"1","key":"10.1016\/j.dsx.2014.04.035_bib0040","article-title":"Pro-inflammatory and prothrombotic factors and metabolic syndrome","volume":"18","author":"Grazyna","year":"2007","journal-title":"eJIFCC"},{"issue":"7","key":"10.1016\/j.dsx.2014.04.035_bib0045","first-page":"19","article-title":"The metabolic syndrome \u2013 an ongoing story","volume":"60","author":"Duvnjak","year":"2009","journal-title":"J Physiol Pharmacol"},{"key":"10.1016\/j.dsx.2014.04.035_bib0050","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1126\/science.7678183","article-title":"Adipose expression of tumor necrosis factor-\u03b1: direct role in obesity-linked insulin resistance","volume":"259","author":"Hotamisligil","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.dsx.2014.04.035_bib0055","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/nm0796-800","article-title":"Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity","volume":"2","author":"Shimomura","year":"1996","journal-title":"Nat Med"},{"key":"10.1016\/j.dsx.2014.04.035_bib0060","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/35053000","article-title":"The hormone resistin links obesity to diabetes","volume":"409","author":"Steppan","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.dsx.2014.04.035_bib0065","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/0026-0495(86)90209-X","article-title":"Correlation between blood fibrinolytic activity, plasminogen activator inhibitor level, plasma insulin level and relative body weight in normal and obese subjects","volume":"35","author":"Vague","year":"1986","journal-title":"Metabolism"},{"key":"10.1016\/j.dsx.2014.04.035_bib0070","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/BF00403280","article-title":"Increased plasma plasminogen activator 1 level. A possible link between insulin resistance and atherothrombosis","volume":"34","author":"Juhan","year":"1991","journal-title":"Diabetologia"},{"key":"10.1016\/j.dsx.2014.04.035_bib0075","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1161\/01.RES.84.9.1085","article-title":"Very low-density lipoprotein activates nuclear factor-kB in endothelial cells","volume":"84","author":"Dichtl","year":"1999","journal-title":"Circ Res"},{"issue":"January\u2013February (1)","key":"10.1016\/j.dsx.2014.04.035_bib0080","doi-asserted-by":"crossref","first-page":"116","DOI":"10.4103\/2230-8210.91206","article-title":"Adipokines (adiponectin and plasminogen activator inhhibitor-1) in metabolic syndrome","volume":"16","author":"Garg","year":"2012","journal-title":"Ind J Endocrinol Metab"},{"key":"10.1016\/j.dsx.2014.04.035_bib0085","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1301\/nr.2003.nov.363-375","article-title":"Lipoprotein metabolism in obesity and diabetes: insights from stable isotope kinetic studies in humans","volume":"61","author":"Marsh","year":"2003","journal-title":"Nutr Rev"},{"issue":"2","key":"10.1016\/j.dsx.2014.04.035_bib0090","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.bbrc.2006.11.058","article-title":"High molecular weight adiponectin reduces apolipoprotein B and E release in human hepatocytes","volume":"352","author":"Neumeier","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.dsx.2014.04.035_bib0095","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.2337\/diab.37.12.1595","article-title":"Role of insulin resistance in human disease","volume":"37","author":"Reaven","year":"1988","journal-title":"Diabetes"},{"key":"10.1016\/j.dsx.2014.04.035_bib0100","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1152\/physrev.1995.75.3.473","article-title":"Pathophysiology of insulin resistance in human disease","volume":"75","author":"Reaven","year":"1995","journal-title":"Physiol Rev"},{"issue":"6","key":"10.1016\/j.dsx.2014.04.035_bib0105","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1007\/s00125-005-1766-7","article-title":"Angiotensin-II-induced oxidative stress elicits hypoadiponectinaemia in rats","volume":"48","author":"Hattori","year":"2005","journal-title":"Diabetologia"},{"key":"10.1016\/j.dsx.2014.04.035_bib0110","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1089\/met.2007.0034","article-title":"Association of adiposity, inflammation and atherosclerosis: the role of adipocytokines and CRP in Asian Indian subjects","volume":"6","author":"Mahadik","year":"2008","journal-title":"Metab Syndr Relat Disord"},{"key":"10.1016\/j.dsx.2014.04.035_bib0115","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.metabol.2004.10.016","article-title":"Association of low adiponectin levels with the metabolic syndrome \u2013 The Chennai Urban Rural Epidemiology Study (CURES-4)","volume":"54","author":"Mohan","year":"2005","journal-title":"Metabolism"},{"key":"10.1016\/j.dsx.2014.04.035_bib0120","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1038\/oby.2002.150","article-title":"Plasma adiponectin levels in overweight and obese Asians","volume":"10","author":"Yang","year":"2002","journal-title":"Obes Res"},{"key":"10.1016\/j.dsx.2014.04.035_bib0125","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/j.metabol.2007.06.015","article-title":"High molecular weight multimer form of adiponectin as a useful marker to evaluate insulin resistance and metabolic syndrome in Japanese men","volume":"56","author":"Seino","year":"2007","journal-title":"Metabolism"},{"key":"10.1016\/j.dsx.2014.04.035_bib0130","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/sj.ijo.0803793","article-title":"Circulating adiponectin levels associate with inflammatory markers, insulin resistance and metabolic syndrome independent of obesity","volume":"32","author":"Hung","year":"2008","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.dsx.2014.04.035_bib0135","first-page":"20","article-title":"Adiponectin lowering in metabolic syndrome and independent relation to hypertriglyceridemia","volume":"48","author":"Tanianski","year":"2008","journal-title":"Kardiologiia"},{"key":"10.1016\/j.dsx.2014.04.035_bib0140","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1080\/07315724.2010.10719831","article-title":"Hypoadiponectinemia is strongly associated with metabolic syndrome in Korean type 2 diabetes patients","volume":"29","author":"Ryu","year":"2010","journal-title":"J Am Coll Nutr"},{"key":"10.1016\/j.dsx.2014.04.035_bib0145","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.2337\/db06-0263","article-title":"Adipose tissue: from lipid storage compartment to endocrine organ","volume":"55","author":"Scherer","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.dsx.2014.04.035_bib0150","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/0026-0495(86)90209-X","article-title":"Correlation between blood fibrinolytic activity, plasminogen activator inhibitor level, plasma insulin level, and relative body weight in normal and obese subjects","volume":"35","author":"Vague","year":"1986","journal-title":"Metabolism"},{"key":"10.1016\/j.dsx.2014.04.035_bib0155","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1172\/JCI118404","article-title":"Distribution and regulation of plasminogen activator inhibitor-1 in murine adipose tissue in vivo. Induction by tumor necrosis factor-alpha and lipopolysaccharide","volume":"97","author":"Samad","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/j.dsx.2014.04.035_bib0160","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1038\/sj.ijo.0803189","article-title":"Among inflammation and coagulation markers, PAI-1 is a true component of the metabolic syndrome","volume":"30","author":"Mertens","year":"2006","journal-title":"Int J Obes (Lond)"},{"issue":"Suppl. 2","key":"10.1016\/j.dsx.2014.04.035_bib0165","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0167-4943(09)70012-3","article-title":"Plasminogen activator inhibitor type 1 (PAI-1) is a valuable biomarker for predicting the metabolic syndrome (MS) in institutionalized elderly residents in Taiwan","volume":"49","author":"Chou","year":"2009","journal-title":"Arch Gerontol Geriatr"},{"key":"10.1016\/j.dsx.2014.04.035_bib0170","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1046\/j.1538-7836.2003.00279.x","article-title":"Plasminogen activator inhibitor-1, inflammation, obesity, insulin resistance and vascular risk","volume":"1","author":"Juhan-Vague","year":"2003","journal-title":"J Thromb Haemost"}],"container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402114000472?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402114000472?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,12]],"date-time":"2019-08-12T23:18:40Z","timestamp":1565651920000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1871402114000472"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S1871402114000472"],"URL":"https:\/\/doi.org\/10.1016\/j.dsx.2014.04.035","relation":{},"ISSN":["1871-4021"],"issn-type":[{"value":"1871-4021","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Imbalance between protective (adiponectin) and prothrombotic (Plasminogen Activator Inhibitor-1) adipokines in metabolic syndrome","name":"articletitle","label":"Article Title"},{"value":"Diabetes & Metabolic Syndrome: Clinical Research & Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dsx.2014.04.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Diabetes India. Published by Diabetes India All rights reserved.","name":"copyright","label":"Copyright"}]}}